CompletedPhase 2NCT01235572
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
Studying Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fred Hutchinson Cancer Center
- Principal Investigator
- Roland WalterFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
- Intervention
- standard follow-up care(procedure)
- Enrollment
- 200 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2010 – 2014
Study locations (1)
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01235572 on ClinicalTrials.gov